215 related articles for article (PubMed ID: 15082024)
41. A functional study on CysLT(1) receptors in human eosinophils.
Ohshima N; Nagase H; Koshino T; Miyamasu M; Yamaguchi M; Hirai K; Yamamoto K; Fujisawa T; Nakagawa N; Kishikawa K; Morita Y
Int Arch Allergy Immunol; 2002 Sep; 129(1):67-75. PubMed ID: 12373000
[TBL] [Abstract][Full Text] [Related]
42. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages.
Thivierge M; Stanková J; Rola-Pleszczynski M
J Immunol; 2001 Sep; 167(5):2855-60. PubMed ID: 11509632
[TBL] [Abstract][Full Text] [Related]
43. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.
Beller TC; Friend DS; Maekawa A; Lam BK; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3047-52. PubMed ID: 14970333
[TBL] [Abstract][Full Text] [Related]
44. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M
Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
[TBL] [Abstract][Full Text] [Related]
45. Human mast cells express two leukotriene C(4) synthase isoenzymes and the CysLT(1) receptor.
Sjöström M; Jakobsson PJ; Juremalm M; Ahmed A; Nilsson G; Macchia L; Haeggström JZ
Biochim Biophys Acta; 2002 Jun; 1583(1):53-62. PubMed ID: 12069849
[TBL] [Abstract][Full Text] [Related]
46. Leukotriene receptors: classification, gene expression, and signal transduction.
Izumi T; Yokomizo T; Obinata H; Ogasawara H; Shimizu T
J Biochem; 2002 Jul; 132(1):1-6. PubMed ID: 12097153
[TBL] [Abstract][Full Text] [Related]
47. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
[TBL] [Abstract][Full Text] [Related]
48. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.
Corrigan C; Mallett K; Ying S; Roberts D; Parikh A; Scadding G; Lee T
J Allergy Clin Immunol; 2005 Feb; 115(2):316-22. PubMed ID: 15696087
[TBL] [Abstract][Full Text] [Related]
49. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
[TBL] [Abstract][Full Text] [Related]
50. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN; Mohammed LA
Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
[TBL] [Abstract][Full Text] [Related]
51. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
52. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S214-9. PubMed ID: 9620942
[TBL] [Abstract][Full Text] [Related]
53. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls.
Tufvesson E; Nihlberg K; Westergren-Thorsson G; Bjermer L
Prostaglandins Leukot Essent Fatty Acids; 2011 Aug; 85(2):67-73. PubMed ID: 21596548
[TBL] [Abstract][Full Text] [Related]
54. Cysteinyl leukotriene signaling through perinuclear CysLT(1) receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression.
Eaton A; Nagy E; Pacault M; Fauconnier J; Bäck M
J Mol Med (Berl); 2012 Oct; 90(10):1223-31. PubMed ID: 22527886
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
[TBL] [Abstract][Full Text] [Related]
56. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses.
Maekawa A; Austen KF; Kanaoka Y
J Biol Chem; 2002 Jun; 277(23):20820-4. PubMed ID: 11932261
[TBL] [Abstract][Full Text] [Related]
57. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
Leff AR
Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
Montuschi P; Sala A; Dahlén SE; Folco G
Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
[TBL] [Abstract][Full Text] [Related]
60. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
